Concord Biotech Limited — Important, 26-02-2026: Updates
26-02-2026 | 02:23 pm
26-02-2026 | 02:23 pm
Concord Biotech's board approved Q3 financial results. Consolidated net profit reached ₹63.64 Cr, impacted by a ₹3.27 Cr one-time employee benefit charge. Paritosh Trivedi was also appointed as the new Company Secretary and Compliance Officer.
No comments yet. Be the first to comment!
